NIIN Output Data
NIIN:
NSN:
Item Name:
PIPERACILLIN SODIUM AND TAZOBACT
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| 02-0560 | 89875 | A | 5 | 1 | 4 | ZZ | ||
| NDC00206-8454-17 | 98377 | A | 3 | 2 | 4 | ZZ | ||
| 6505NCM010330 | 64616 | A | 5 | 1 | 4 | ZZ | ||
| NDC00206-8454-17 | 0GZ31 | F | 5 | 9 | 4 | ZZ | ||
| ZOSYN | 0GZ31 | F | 5 | 9 | 4 | ZZ |
CAGE Information
| Code | Company |
|---|---|
| 0GZ31 | WYETH-AYERST LABORATORIES ORDER DEPT |
| 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE |
| 98377 | PFIZER INC. DBA WYETH |
| 64616 | DEFENSE MEDICAL STANDARDIZATION BOAR |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PIPERACILLIN/TOZOBACTAM SODIUM FOR INJECTION 10S |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CBBL | FEATURES PROVIDED | STERILE |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.000 KILOGRAMS PER CUBIC DECIMETER PIPERACILLIN CRYSTINE, W/W AND 0.375 KILOGRAMS PER CUBIC DECIMETER TAZOBACTAM CRYSTINE, W/W |
| FEAT | SPECIAL FEATURES | EACH ADD-VANTAGE VIAL CONTAINS 7.04 MEQ OF SODIUM; FOR HOSPITAL PATIENTS WITH SERIOUS INFECTIONS; ZOYSN IS PRESERVATIVE FREE; VIALS SHOULD BE STORED AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F) PRIOR TO RECONSTITUTION |
| CSGS | ADMINISTRATION | INTRAVENOUS |